Could AI and Automation Find Better Treatments for Cancer – and Maybe Aging?
CNN explores how AI is transforming the field of medicine, particularly in developing new cancer treatments. The London-based company, LabGenius, is pioneering an automated robotic system capable of creating and testing thousands of unique therapeutic molecules efficiently. This method significantly advances the speed and accuracy of drug discovery, potentially paving the way for treatments that can better target cancer cells with less debilitating side effects. The ultimate goal? To not just tackle cancer but also address the root causes of ageing.
Key Points
- LabGenius utilises AI to automate the creation of therapeutic molecules, enabling faster drug discovery.
- The technology allows for experiments that generate new molecules designed to selectively kill diseased cells.
- They claim to have developed novel molecules with significantly improved ability to target cancer cells.
- The company aims to begin clinical trials for their treatments by 2027.
- There’s potential for this technology to also address issues related to ageing, not just cancer.
Why should I read this?
This article is a real eye-opener for anyone interested in the cutting-edge intersection of AI and medicine. It highlights how technology is not just speeding up the drug discovery process but is also potentially redefining it—focusing on precision and efficiency that could lead to groundbreaking treatments for both cancer and ageing. Seriously, if you care about the future of healthcare, you won’t want to miss this!